Clinical trials
Terminated Lupus Erythematosus, Systemic trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| UCB Pharma | 2 |
| Amgen | 1 |
| Cephalon, Inc. | 1 |
| EMD Serono | 1 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Janssen Research & Development, LLC | 1 |
| La Jolla Pharmaceutical Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 16 |
| Lupus Nephritis | 3 |
| Lupus Erythematosus, Cutaneous | 1 |
| Nephritis | 1 |
| Proteinuria | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.